Nuclear factor kappaB--a new therapeutic approach?
- PMID: 9876973
- DOI: 10.1007/s001340050734
Nuclear factor kappaB--a new therapeutic approach?
Comment on
-
Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy.Intensive Care Med. 1998 Nov;24(11):1131-8. doi: 10.1007/s001340050735. Intensive Care Med. 1998. PMID: 9876974 Free PMC article. Review.
-
Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite.Intensive Care Med. 1998 Nov;24(11):1199-208. doi: 10.1007/s001340050745. Intensive Care Med. 1998. PMID: 9876984
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
